nodes	percent_of_prediction	percent_of_DWPC	metapath
Lenalidomide—PTGS2—Triamcinolone—psoriatic arthritis	0.15	0.255	CbGbCtD
Lenalidomide—PTGS2—Betamethasone—psoriatic arthritis	0.129	0.219	CbGbCtD
Lenalidomide—PTGS2—Dexamethasone—psoriatic arthritis	0.0749	0.127	CbGbCtD
Lenalidomide—ABCB1—Methylprednisolone—psoriatic arthritis	0.0653	0.111	CbGbCtD
Lenalidomide—TNFSF11—skeletal joint—psoriatic arthritis	0.0576	0.439	CbGeAlD
Lenalidomide—TNFSF11—synovial membrane of synovial joint—psoriatic arthritis	0.0437	0.333	CbGeAlD
Lenalidomide—ABCB1—Betamethasone—psoriatic arthritis	0.0425	0.0723	CbGbCtD
Lenalidomide—ABCB1—Prednisolone—psoriatic arthritis	0.0419	0.0713	CbGbCtD
Lenalidomide—ABCB1—Prednisone—psoriatic arthritis	0.0396	0.0674	CbGbCtD
Lenalidomide—ABCB1—Dexamethasone—psoriatic arthritis	0.0247	0.042	CbGbCtD
Lenalidomide—ABCB1—Methotrexate—psoriatic arthritis	0.0199	0.0338	CbGbCtD
Lenalidomide—PTGS2—skeletal joint—psoriatic arthritis	0.00749	0.0571	CbGeAlD
Lenalidomide—TNFSF11—tendon—psoriatic arthritis	0.00662	0.0504	CbGeAlD
Lenalidomide—Pomalidomide—TNF—psoriatic arthritis	0.00597	0.608	CrCbGaD
Lenalidomide—PTGS2—synovial membrane of synovial joint—psoriatic arthritis	0.00569	0.0434	CbGeAlD
Lenalidomide—CDH5—tendon—psoriatic arthritis	0.00498	0.0379	CbGeAlD
Lenalidomide—Thalidomide—TNF—psoriatic arthritis	0.00385	0.392	CrCbGaD
Lenalidomide—CRBN—tendon—psoriatic arthritis	0.00316	0.0241	CbGeAlD
Lenalidomide—PTGS2—skin of body—psoriatic arthritis	0.00113	0.00862	CbGeAlD
Lenalidomide—PTGS2—Fluocinonide—Methylprednisolone—psoriatic arthritis	0.00101	0.159	CbGdCrCtD
Lenalidomide—PTGS2—Fluocinonide—Betamethasone—psoriatic arthritis	0.00099	0.156	CbGdCrCtD
Lenalidomide—PTGS2—Fluocinonide—Dexamethasone—psoriatic arthritis	0.00099	0.156	CbGdCrCtD
Lenalidomide—PTGS2—Fluocinonide—Triamcinolone—psoriatic arthritis	0.000967	0.153	CbGdCrCtD
Lenalidomide—PTGS2—tendon—psoriatic arthritis	0.000861	0.00656	CbGeAlD
Lenalidomide—PTGS2—Fluticasone Propionate—Methylprednisolone—psoriatic arthritis	0.000607	0.0957	CbGdCrCtD
Lenalidomide—PTGS2—Fluticasone Propionate—Dexamethasone—psoriatic arthritis	0.000597	0.0942	CbGdCrCtD
Lenalidomide—PTGS2—Fluticasone Propionate—Betamethasone—psoriatic arthritis	0.000597	0.0942	CbGdCrCtD
Lenalidomide—PTGS2—Fluticasone Propionate—Triamcinolone—psoriatic arthritis	0.000584	0.0921	CbGdCrCtD
Lenalidomide—Infection—Methylprednisolone—psoriatic arthritis	0.000149	0.000564	CcSEcCtD
Lenalidomide—Haematuria—Methotrexate—psoriatic arthritis	0.000149	0.000561	CcSEcCtD
Lenalidomide—Shock—Triamcinolone—psoriatic arthritis	0.000148	0.000559	CcSEcCtD
Lenalidomide—Insomnia—Prednisolone—psoriatic arthritis	0.000148	0.000559	CcSEcCtD
Lenalidomide—Alopecia—Prednisone—psoriatic arthritis	0.000148	0.000559	CcSEcCtD
Lenalidomide—Shock—Methylprednisolone—psoriatic arthritis	0.000148	0.000558	CcSEcCtD
Lenalidomide—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000148	0.000557	CcSEcCtD
Lenalidomide—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000147	0.000556	CcSEcCtD
Lenalidomide—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000147	0.000556	CcSEcCtD
Lenalidomide—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000147	0.000556	CcSEcCtD
Lenalidomide—Epistaxis—Methotrexate—psoriatic arthritis	0.000147	0.000555	CcSEcCtD
Lenalidomide—Paraesthesia—Prednisolone—psoriatic arthritis	0.000147	0.000555	CcSEcCtD
Lenalidomide—Tachycardia—Triamcinolone—psoriatic arthritis	0.000147	0.000555	CcSEcCtD
Lenalidomide—Mental disorder—Prednisone—psoriatic arthritis	0.000147	0.000554	CcSEcCtD
Lenalidomide—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000147	0.000554	CcSEcCtD
Lenalidomide—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000146	0.000551	CcSEcCtD
Lenalidomide—Erythema—Prednisone—psoriatic arthritis	0.000146	0.00055	CcSEcCtD
Lenalidomide—Malnutrition—Prednisone—psoriatic arthritis	0.000146	0.00055	CcSEcCtD
Lenalidomide—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000146	0.00055	CcSEcCtD
Lenalidomide—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000146	0.000549	CcSEcCtD
Lenalidomide—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000145	0.000548	CcSEcCtD
Lenalidomide—Hypertension—Betamethasone—psoriatic arthritis	0.000145	0.000546	CcSEcCtD
Lenalidomide—Hypertension—Dexamethasone—psoriatic arthritis	0.000145	0.000546	CcSEcCtD
Lenalidomide—Myalgia—Betamethasone—psoriatic arthritis	0.000143	0.000538	CcSEcCtD
Lenalidomide—Myalgia—Dexamethasone—psoriatic arthritis	0.000143	0.000538	CcSEcCtD
Lenalidomide—Anxiety—Dexamethasone—psoriatic arthritis	0.000142	0.000536	CcSEcCtD
Lenalidomide—Anxiety—Betamethasone—psoriatic arthritis	0.000142	0.000536	CcSEcCtD
Lenalidomide—Discomfort—Dexamethasone—psoriatic arthritis	0.000141	0.000532	CcSEcCtD
Lenalidomide—Discomfort—Betamethasone—psoriatic arthritis	0.000141	0.000532	CcSEcCtD
Lenalidomide—Haemoglobin—Methotrexate—psoriatic arthritis	0.000141	0.000531	CcSEcCtD
Lenalidomide—Hypotension—Methylprednisolone—psoriatic arthritis	0.000141	0.00053	CcSEcCtD
Lenalidomide—Pain—Prednisolone—psoriatic arthritis	0.00014	0.000529	CcSEcCtD
Lenalidomide—Haemorrhage—Methotrexate—psoriatic arthritis	0.00014	0.000528	CcSEcCtD
Lenalidomide—Hepatitis—Methotrexate—psoriatic arthritis	0.00014	0.000528	CcSEcCtD
Lenalidomide—Pharyngitis—Methotrexate—psoriatic arthritis	0.000139	0.000525	CcSEcCtD
Lenalidomide—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000138	0.000522	CcSEcCtD
Lenalidomide—Vision blurred—Prednisone—psoriatic arthritis	0.000138	0.000519	CcSEcCtD
Lenalidomide—Urethral disorder—Methotrexate—psoriatic arthritis	0.000137	0.000518	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000137	0.000518	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000137	0.000517	CcSEcCtD
Lenalidomide—Oedema—Betamethasone—psoriatic arthritis	0.000137	0.000516	CcSEcCtD
Lenalidomide—Oedema—Dexamethasone—psoriatic arthritis	0.000137	0.000516	CcSEcCtD
Lenalidomide—Insomnia—Triamcinolone—psoriatic arthritis	0.000136	0.000514	CcSEcCtD
Lenalidomide—Insomnia—Methylprednisolone—psoriatic arthritis	0.000136	0.000513	CcSEcCtD
Lenalidomide—Infection—Dexamethasone—psoriatic arthritis	0.000136	0.000512	CcSEcCtD
Lenalidomide—Infection—Betamethasone—psoriatic arthritis	0.000136	0.000512	CcSEcCtD
Lenalidomide—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000135	0.000511	CcSEcCtD
Lenalidomide—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000135	0.000511	CcSEcCtD
Lenalidomide—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000135	0.000509	CcSEcCtD
Lenalidomide—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000135	0.000509	CcSEcCtD
Lenalidomide—Visual impairment—Methotrexate—psoriatic arthritis	0.000135	0.000509	CcSEcCtD
Lenalidomide—Anaemia—Prednisone—psoriatic arthritis	0.000135	0.000509	CcSEcCtD
Lenalidomide—Shock—Dexamethasone—psoriatic arthritis	0.000135	0.000508	CcSEcCtD
Lenalidomide—Shock—Betamethasone—psoriatic arthritis	0.000135	0.000508	CcSEcCtD
Lenalidomide—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000134	0.000507	CcSEcCtD
Lenalidomide—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000134	0.000506	CcSEcCtD
Lenalidomide—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000134	0.000506	CcSEcCtD
Lenalidomide—Agitation—Prednisone—psoriatic arthritis	0.000134	0.000506	CcSEcCtD
Lenalidomide—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000134	0.000505	CcSEcCtD
Lenalidomide—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000134	0.000505	CcSEcCtD
Lenalidomide—Tachycardia—Betamethasone—psoriatic arthritis	0.000133	0.000503	CcSEcCtD
Lenalidomide—Tachycardia—Dexamethasone—psoriatic arthritis	0.000133	0.000503	CcSEcCtD
Lenalidomide—Angioedema—Prednisone—psoriatic arthritis	0.000133	0.000503	CcSEcCtD
Lenalidomide—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000133	0.0005	CcSEcCtD
Lenalidomide—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000132	0.0005	CcSEcCtD
Lenalidomide—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000132	0.000499	CcSEcCtD
Lenalidomide—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000132	0.000499	CcSEcCtD
Lenalidomide—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000132	0.000499	CcSEcCtD
Lenalidomide—Malaise—Prednisone—psoriatic arthritis	0.000132	0.000496	CcSEcCtD
Lenalidomide—Vertigo—Prednisone—psoriatic arthritis	0.000131	0.000495	CcSEcCtD
Lenalidomide—Eye disorder—Methotrexate—psoriatic arthritis	0.000131	0.000494	CcSEcCtD
Lenalidomide—Syncope—Prednisone—psoriatic arthritis	0.000131	0.000494	CcSEcCtD
Lenalidomide—Tinnitus—Methotrexate—psoriatic arthritis	0.000131	0.000493	CcSEcCtD
Lenalidomide—Anorexia—Dexamethasone—psoriatic arthritis	0.00013	0.000492	CcSEcCtD
Lenalidomide—Anorexia—Betamethasone—psoriatic arthritis	0.00013	0.000492	CcSEcCtD
Lenalidomide—Urticaria—Prednisolone—psoriatic arthritis	0.00013	0.000491	CcSEcCtD
Lenalidomide—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00013	0.00049	CcSEcCtD
Lenalidomide—Fatigue—Triamcinolone—psoriatic arthritis	0.00013	0.00049	CcSEcCtD
Lenalidomide—Fatigue—Methylprednisolone—psoriatic arthritis	0.00013	0.000489	CcSEcCtD
Lenalidomide—Pain—Triamcinolone—psoriatic arthritis	0.000129	0.000486	CcSEcCtD
Lenalidomide—Loss of consciousness—Prednisone—psoriatic arthritis	0.000128	0.000484	CcSEcCtD
Lenalidomide—Hypotension—Betamethasone—psoriatic arthritis	0.000128	0.000482	CcSEcCtD
Lenalidomide—Hypotension—Dexamethasone—psoriatic arthritis	0.000128	0.000482	CcSEcCtD
Lenalidomide—Angiopathy—Methotrexate—psoriatic arthritis	0.000127	0.000479	CcSEcCtD
Lenalidomide—Immune system disorder—Methotrexate—psoriatic arthritis	0.000127	0.000477	CcSEcCtD
Lenalidomide—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000126	0.000476	CcSEcCtD
Lenalidomide—Hypertension—Prednisone—psoriatic arthritis	0.000126	0.000475	CcSEcCtD
Lenalidomide—Chills—Methotrexate—psoriatic arthritis	0.000126	0.000474	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000125	0.00047	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000125	0.00047	CcSEcCtD
Lenalidomide—Myalgia—Prednisone—psoriatic arthritis	0.000124	0.000469	CcSEcCtD
Lenalidomide—Arthralgia—Prednisone—psoriatic arthritis	0.000124	0.000469	CcSEcCtD
Lenalidomide—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000124	0.000469	CcSEcCtD
Lenalidomide—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000124	0.000467	CcSEcCtD
Lenalidomide—Anxiety—Prednisone—psoriatic arthritis	0.000124	0.000467	CcSEcCtD
Lenalidomide—Alopecia—Methotrexate—psoriatic arthritis	0.000124	0.000467	CcSEcCtD
Lenalidomide—Insomnia—Betamethasone—psoriatic arthritis	0.000124	0.000467	CcSEcCtD
Lenalidomide—Insomnia—Dexamethasone—psoriatic arthritis	0.000124	0.000467	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000123	0.000465	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000123	0.000464	CcSEcCtD
Lenalidomide—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000123	0.000463	CcSEcCtD
Lenalidomide—Paraesthesia—Betamethasone—psoriatic arthritis	0.000123	0.000463	CcSEcCtD
Lenalidomide—Discomfort—Prednisone—psoriatic arthritis	0.000123	0.000463	CcSEcCtD
Lenalidomide—Mental disorder—Methotrexate—psoriatic arthritis	0.000123	0.000463	CcSEcCtD
Lenalidomide—Erythema—Methotrexate—psoriatic arthritis	0.000122	0.00046	CcSEcCtD
Lenalidomide—Malnutrition—Methotrexate—psoriatic arthritis	0.000122	0.00046	CcSEcCtD
Lenalidomide—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000121	0.000455	CcSEcCtD
Lenalidomide—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00012	0.000454	CcSEcCtD
Lenalidomide—Dyspepsia—Betamethasone—psoriatic arthritis	0.00012	0.000454	CcSEcCtD
Lenalidomide—Urticaria—Triamcinolone—psoriatic arthritis	0.00012	0.000452	CcSEcCtD
Lenalidomide—Urticaria—Methylprednisolone—psoriatic arthritis	0.000119	0.000451	CcSEcCtD
Lenalidomide—Dysgeusia—Methotrexate—psoriatic arthritis	0.000119	0.000451	CcSEcCtD
Lenalidomide—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000119	0.000449	CcSEcCtD
Lenalidomide—Oedema—Prednisone—psoriatic arthritis	0.000119	0.000449	CcSEcCtD
Lenalidomide—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000119	0.000448	CcSEcCtD
Lenalidomide—Decreased appetite—Betamethasone—psoriatic arthritis	0.000119	0.000448	CcSEcCtD
Lenalidomide—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000119	0.000448	CcSEcCtD
Lenalidomide—Infection—Prednisone—psoriatic arthritis	0.000118	0.000446	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000118	0.000445	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000118	0.000445	CcSEcCtD
Lenalidomide—Back pain—Methotrexate—psoriatic arthritis	0.000118	0.000445	CcSEcCtD
Lenalidomide—Fatigue—Dexamethasone—psoriatic arthritis	0.000118	0.000445	CcSEcCtD
Lenalidomide—Fatigue—Betamethasone—psoriatic arthritis	0.000118	0.000445	CcSEcCtD
Lenalidomide—Shock—Prednisone—psoriatic arthritis	0.000117	0.000442	CcSEcCtD
Lenalidomide—Pain—Dexamethasone—psoriatic arthritis	0.000117	0.000441	CcSEcCtD
Lenalidomide—Pain—Betamethasone—psoriatic arthritis	0.000117	0.000441	CcSEcCtD
Lenalidomide—Nervous system disorder—Prednisone—psoriatic arthritis	0.000117	0.000441	CcSEcCtD
Lenalidomide—Tachycardia—Prednisone—psoriatic arthritis	0.000116	0.000438	CcSEcCtD
Lenalidomide—Skin disorder—Prednisone—psoriatic arthritis	0.000116	0.000436	CcSEcCtD
Lenalidomide—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000115	0.000434	CcSEcCtD
Lenalidomide—Vision blurred—Methotrexate—psoriatic arthritis	0.000115	0.000434	CcSEcCtD
Lenalidomide—Anorexia—Prednisone—psoriatic arthritis	0.000114	0.000428	CcSEcCtD
Lenalidomide—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000113	0.000427	CcSEcCtD
Lenalidomide—Anaemia—Methotrexate—psoriatic arthritis	0.000113	0.000425	CcSEcCtD
Lenalidomide—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000113	0.000425	CcSEcCtD
Lenalidomide—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000113	0.000425	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000112	0.000422	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000112	0.000422	CcSEcCtD
Lenalidomide—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000111	0.000419	CcSEcCtD
Lenalidomide—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000111	0.000418	CcSEcCtD
Lenalidomide—Malaise—Methotrexate—psoriatic arthritis	0.00011	0.000415	CcSEcCtD
Lenalidomide—Vertigo—Methotrexate—psoriatic arthritis	0.00011	0.000413	CcSEcCtD
Lenalidomide—Leukopenia—Methotrexate—psoriatic arthritis	0.000109	0.000412	CcSEcCtD
Lenalidomide—Urticaria—Dexamethasone—psoriatic arthritis	0.000109	0.00041	CcSEcCtD
Lenalidomide—Urticaria—Betamethasone—psoriatic arthritis	0.000109	0.00041	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000108	0.000409	CcSEcCtD
Lenalidomide—Dizziness—Prednisolone—psoriatic arthritis	0.000108	0.000409	CcSEcCtD
Lenalidomide—Asthenia—Triamcinolone—psoriatic arthritis	0.000108	0.000408	CcSEcCtD
Lenalidomide—Abdominal pain—Betamethasone—psoriatic arthritis	0.000108	0.000408	CcSEcCtD
Lenalidomide—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000108	0.000408	CcSEcCtD
Lenalidomide—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000108	0.000408	CcSEcCtD
Lenalidomide—Body temperature increased—Betamethasone—psoriatic arthritis	0.000108	0.000408	CcSEcCtD
Lenalidomide—Asthenia—Methylprednisolone—psoriatic arthritis	0.000108	0.000407	CcSEcCtD
Lenalidomide—Insomnia—Prednisone—psoriatic arthritis	0.000108	0.000406	CcSEcCtD
Lenalidomide—Paraesthesia—Prednisone—psoriatic arthritis	0.000107	0.000403	CcSEcCtD
Lenalidomide—Pruritus—Triamcinolone—psoriatic arthritis	0.000107	0.000402	CcSEcCtD
Lenalidomide—Cough—Methotrexate—psoriatic arthritis	0.000106	0.000401	CcSEcCtD
Lenalidomide—Pruritus—Methylprednisolone—psoriatic arthritis	0.000106	0.000401	CcSEcCtD
Lenalidomide—Dyspepsia—Prednisone—psoriatic arthritis	0.000105	0.000395	CcSEcCtD
Lenalidomide—Chest pain—Methotrexate—psoriatic arthritis	0.000104	0.000392	CcSEcCtD
Lenalidomide—Myalgia—Methotrexate—psoriatic arthritis	0.000104	0.000392	CcSEcCtD
Lenalidomide—Arthralgia—Methotrexate—psoriatic arthritis	0.000104	0.000392	CcSEcCtD
Lenalidomide—Decreased appetite—Prednisone—psoriatic arthritis	0.000104	0.000391	CcSEcCtD
Lenalidomide—Rash—Prednisolone—psoriatic arthritis	0.000103	0.00039	CcSEcCtD
Lenalidomide—Dermatitis—Prednisolone—psoriatic arthritis	0.000103	0.000389	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000103	0.000389	CcSEcCtD
Lenalidomide—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000103	0.000388	CcSEcCtD
Lenalidomide—Fatigue—Prednisone—psoriatic arthritis	0.000103	0.000387	CcSEcCtD
Lenalidomide—Headache—Prednisolone—psoriatic arthritis	0.000103	0.000387	CcSEcCtD
Lenalidomide—Discomfort—Methotrexate—psoriatic arthritis	0.000103	0.000387	CcSEcCtD
Lenalidomide—Constipation—Prednisone—psoriatic arthritis	0.000102	0.000384	CcSEcCtD
Lenalidomide—Confusional state—Methotrexate—psoriatic arthritis	0.0001	0.000379	CcSEcCtD
Lenalidomide—Dizziness—Triamcinolone—psoriatic arthritis	9.97e-05	0.000376	CcSEcCtD
Lenalidomide—Dizziness—Methylprednisolone—psoriatic arthritis	9.94e-05	0.000375	CcSEcCtD
Lenalidomide—Infection—Methotrexate—psoriatic arthritis	9.89e-05	0.000373	CcSEcCtD
Lenalidomide—Feeling abnormal—Prednisone—psoriatic arthritis	9.81e-05	0.00037	CcSEcCtD
Lenalidomide—Asthenia—Dexamethasone—psoriatic arthritis	9.81e-05	0.00037	CcSEcCtD
Lenalidomide—Asthenia—Betamethasone—psoriatic arthritis	9.81e-05	0.00037	CcSEcCtD
Lenalidomide—Nervous system disorder—Methotrexate—psoriatic arthritis	9.76e-05	0.000368	CcSEcCtD
Lenalidomide—Thrombocytopenia—Methotrexate—psoriatic arthritis	9.74e-05	0.000368	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Prednisone—psoriatic arthritis	9.74e-05	0.000367	CcSEcCtD
Lenalidomide—Nausea—Prednisolone—psoriatic arthritis	9.73e-05	0.000367	CcSEcCtD
Lenalidomide—Pruritus—Dexamethasone—psoriatic arthritis	9.67e-05	0.000365	CcSEcCtD
Lenalidomide—Pruritus—Betamethasone—psoriatic arthritis	9.67e-05	0.000365	CcSEcCtD
Lenalidomide—Skin disorder—Methotrexate—psoriatic arthritis	9.67e-05	0.000365	CcSEcCtD
Lenalidomide—Hyperhidrosis—Methotrexate—psoriatic arthritis	9.62e-05	0.000363	CcSEcCtD
Lenalidomide—Vomiting—Triamcinolone—psoriatic arthritis	9.58e-05	0.000361	CcSEcCtD
Lenalidomide—Vomiting—Methylprednisolone—psoriatic arthritis	9.56e-05	0.000361	CcSEcCtD
Lenalidomide—Rash—Triamcinolone—psoriatic arthritis	9.5e-05	0.000358	CcSEcCtD
Lenalidomide—Dermatitis—Triamcinolone—psoriatic arthritis	9.49e-05	0.000358	CcSEcCtD
Lenalidomide—Anorexia—Methotrexate—psoriatic arthritis	9.49e-05	0.000358	CcSEcCtD
Lenalidomide—Rash—Methylprednisolone—psoriatic arthritis	9.48e-05	0.000358	CcSEcCtD
Lenalidomide—Dermatitis—Methylprednisolone—psoriatic arthritis	9.47e-05	0.000357	CcSEcCtD
Lenalidomide—Urticaria—Prednisone—psoriatic arthritis	9.46e-05	0.000357	CcSEcCtD
Lenalidomide—Headache—Triamcinolone—psoriatic arthritis	9.44e-05	0.000356	CcSEcCtD
Lenalidomide—Headache—Methylprednisolone—psoriatic arthritis	9.42e-05	0.000355	CcSEcCtD
Lenalidomide—Body temperature increased—Prednisone—psoriatic arthritis	9.41e-05	0.000355	CcSEcCtD
Lenalidomide—Abdominal pain—Prednisone—psoriatic arthritis	9.41e-05	0.000355	CcSEcCtD
Lenalidomide—Diarrhoea—Dexamethasone—psoriatic arthritis	9.36e-05	0.000353	CcSEcCtD
Lenalidomide—Diarrhoea—Betamethasone—psoriatic arthritis	9.36e-05	0.000353	CcSEcCtD
Lenalidomide—Hypotension—Methotrexate—psoriatic arthritis	9.3e-05	0.000351	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	9.07e-05	0.000342	CcSEcCtD
Lenalidomide—Dizziness—Betamethasone—psoriatic arthritis	9.04e-05	0.000341	CcSEcCtD
Lenalidomide—Dizziness—Dexamethasone—psoriatic arthritis	9.04e-05	0.000341	CcSEcCtD
Lenalidomide—Insomnia—Methotrexate—psoriatic arthritis	9e-05	0.00034	CcSEcCtD
Lenalidomide—Nausea—Triamcinolone—psoriatic arthritis	8.95e-05	0.000338	CcSEcCtD
Lenalidomide—Paraesthesia—Methotrexate—psoriatic arthritis	8.94e-05	0.000337	CcSEcCtD
Lenalidomide—Nausea—Methylprednisolone—psoriatic arthritis	8.93e-05	0.000337	CcSEcCtD
Lenalidomide—Dyspnoea—Methotrexate—psoriatic arthritis	8.87e-05	0.000335	CcSEcCtD
Lenalidomide—Somnolence—Methotrexate—psoriatic arthritis	8.85e-05	0.000334	CcSEcCtD
Lenalidomide—Hypersensitivity—Prednisone—psoriatic arthritis	8.77e-05	0.000331	CcSEcCtD
Lenalidomide—Dyspepsia—Methotrexate—psoriatic arthritis	8.76e-05	0.00033	CcSEcCtD
Lenalidomide—Vomiting—Dexamethasone—psoriatic arthritis	8.69e-05	0.000328	CcSEcCtD
Lenalidomide—Vomiting—Betamethasone—psoriatic arthritis	8.69e-05	0.000328	CcSEcCtD
Lenalidomide—Decreased appetite—Methotrexate—psoriatic arthritis	8.65e-05	0.000326	CcSEcCtD
Lenalidomide—Rash—Betamethasone—psoriatic arthritis	8.62e-05	0.000325	CcSEcCtD
Lenalidomide—Rash—Dexamethasone—psoriatic arthritis	8.62e-05	0.000325	CcSEcCtD
Lenalidomide—Dermatitis—Betamethasone—psoriatic arthritis	8.61e-05	0.000325	CcSEcCtD
Lenalidomide—Dermatitis—Dexamethasone—psoriatic arthritis	8.61e-05	0.000325	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	8.59e-05	0.000324	CcSEcCtD
Lenalidomide—Fatigue—Methotrexate—psoriatic arthritis	8.58e-05	0.000324	CcSEcCtD
Lenalidomide—Headache—Betamethasone—psoriatic arthritis	8.57e-05	0.000323	CcSEcCtD
Lenalidomide—Headache—Dexamethasone—psoriatic arthritis	8.57e-05	0.000323	CcSEcCtD
Lenalidomide—Asthenia—Prednisone—psoriatic arthritis	8.54e-05	0.000322	CcSEcCtD
Lenalidomide—Pain—Methotrexate—psoriatic arthritis	8.51e-05	0.000321	CcSEcCtD
Lenalidomide—Pruritus—Prednisone—psoriatic arthritis	8.43e-05	0.000318	CcSEcCtD
Lenalidomide—Feeling abnormal—Methotrexate—psoriatic arthritis	8.2e-05	0.000309	CcSEcCtD
Lenalidomide—Diarrhoea—Prednisone—psoriatic arthritis	8.15e-05	0.000307	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Methotrexate—psoriatic arthritis	8.14e-05	0.000307	CcSEcCtD
Lenalidomide—Nausea—Dexamethasone—psoriatic arthritis	8.12e-05	0.000306	CcSEcCtD
Lenalidomide—Nausea—Betamethasone—psoriatic arthritis	8.12e-05	0.000306	CcSEcCtD
Lenalidomide—Urticaria—Methotrexate—psoriatic arthritis	7.91e-05	0.000298	CcSEcCtD
Lenalidomide—Dizziness—Prednisone—psoriatic arthritis	7.88e-05	0.000297	CcSEcCtD
Lenalidomide—Abdominal pain—Methotrexate—psoriatic arthritis	7.87e-05	0.000297	CcSEcCtD
Lenalidomide—Body temperature increased—Methotrexate—psoriatic arthritis	7.87e-05	0.000297	CcSEcCtD
Lenalidomide—Vomiting—Prednisone—psoriatic arthritis	7.57e-05	0.000286	CcSEcCtD
Lenalidomide—Rash—Prednisone—psoriatic arthritis	7.51e-05	0.000283	CcSEcCtD
Lenalidomide—Dermatitis—Prednisone—psoriatic arthritis	7.5e-05	0.000283	CcSEcCtD
Lenalidomide—Headache—Prednisone—psoriatic arthritis	7.46e-05	0.000281	CcSEcCtD
Lenalidomide—Hypersensitivity—Methotrexate—psoriatic arthritis	7.33e-05	0.000277	CcSEcCtD
Lenalidomide—Asthenia—Methotrexate—psoriatic arthritis	7.14e-05	0.000269	CcSEcCtD
Lenalidomide—Nausea—Prednisone—psoriatic arthritis	7.07e-05	0.000267	CcSEcCtD
Lenalidomide—Pruritus—Methotrexate—psoriatic arthritis	7.04e-05	0.000266	CcSEcCtD
Lenalidomide—Diarrhoea—Methotrexate—psoriatic arthritis	6.81e-05	0.000257	CcSEcCtD
Lenalidomide—Dizziness—Methotrexate—psoriatic arthritis	6.58e-05	0.000248	CcSEcCtD
Lenalidomide—Vomiting—Methotrexate—psoriatic arthritis	6.33e-05	0.000239	CcSEcCtD
Lenalidomide—Rash—Methotrexate—psoriatic arthritis	6.28e-05	0.000237	CcSEcCtD
Lenalidomide—Dermatitis—Methotrexate—psoriatic arthritis	6.27e-05	0.000237	CcSEcCtD
Lenalidomide—Headache—Methotrexate—psoriatic arthritis	6.23e-05	0.000235	CcSEcCtD
Lenalidomide—Nausea—Methotrexate—psoriatic arthritis	5.91e-05	0.000223	CcSEcCtD
